NEWS

Approximately 40% of patients treated with anthracyclines are still not receiving National Comprehensive Cancer Network (NCCN) guideline–adherent prophylaxis for chemotherapy-induced vomiting. In most cases, guideline nonadherence was secondary to the lack of a neurokinin 1 (NK1) antagonist. Patients on highly emetogenic chemotherapy should receive prophylaxis in the form of a 5-HT3 antagonist in combination with […]

A REPORT ON CANCER More Than 800 Medicines and Vaccines in Clinical Testing for Cancer Offer New Hope to Patients In recent decades, tremendous – almost previously unthinkable – progress has been made in the fight against cancer. Advances in molecular and genomic research have revealed underlying complexities and provided insights into cancer, which we […]

A Council Bluffs family is furious. Their daughter is battling cancer. She is on a very strict drug maintenance program.When they went to pick up her chemotherapy drugs, they ran into one hurdle after another. "She asked me if she was going to die. That was the hardest," said Makayla Umphreys, Gracie’s mom. Click here […]

NCODA’s View: This article highlights some of the challenges and issues that exist when you separate patients from the care and services they require. Cancer patients can be particular affected by this fragmentation and will benefit greatly by the expertise and capability of receiving their medications from their oncologist with a dedicated dispensing department. Having […]

NCODA’s View: Proper handling and disposal of hazardous drugs is important. Dispensing practices can have a major impact in the education of patients and caregivers to help minimize exposure to these potentially harmful medications. The Ins and Outs Article – Click here to read more. TOP – May 2015, Vol 8, No 2 – CONFERENCE […]

April 2015 marks the one-year anniversary for the beginning of National Community Oncology Dispensing Association, Inc. (NCODA). Recognizing the growing separation between direct patient oversight and delivery of therapy, a group of dedicated pharmacists from New York gathered together to reverse the trend. Believing the best place for quality patient care lies with the treating […]

March 19, 2015 (Syracuse, NY) – The ever changing environment of new treatment options for cancer patients is rapidly moving to a mix of intravenous and oral therapies. The increase in oral treatment options has led to many challenges in the current model of obtaining and delivering quality patient care. The National Community Oncology Dispensing […]